greeksoup/ stock research

Astera Labs (ALAB) Q3 FY2024 earnings: revenue $113 million, up 206.2% on the year

Astera Labs, Inc. (ALAB) reported revenue of $113 million for Q3 FY2024, the quarter ended 30 September 2024, up 206.2% on the same quarter a year earlier. Net income was -$8 million, and diluted earnings per share $-0.05. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2024.

Revenue$113 millionup 206.2%
Net income-$8 million
Diluted EPS$-0.05
QuarterQ3 FY2024ended 30 September 2024

The quarter, against the one before and a year earlier

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Revenue11376.836.9+206.2%
Cost of revenue25.217.08.8+185.7%
Gross profit87.959.928.1+212.7%
Gross margin77.7%77.9%76.1%
Research and development50.740.120.6+145.6%
Operating income-8.9-24.3-2.0n/a
Operating margin-7.9%-31.7%-5.4%
Pre-tax income2.0-14.1-0.3n/a
Income tax9.6-6.52.9+234.7%
Effective tax rate476.6%n/an/a
Net income-7.6-7.5-3.1n/a
Net margin-6.7%-9.8%-8.5%
Diluted EPS-$0.05-$0.05-$0.08n/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Operating cash flow63.529.8-0.3n/a
Capital expenditure16.7n/a0.7+2168.6%
Free cash flow46.8n/a-1.1n/a
Free cash flow margin41.4%n/a-2.9%
Cash from investing-359-302-56.3n/a
Cash from financing1.0-2.30.6+47.8%
Depreciation and amortisation0.80.7n/an/a
Share-based compensation45.543.12.7+1579.6%
Diluted shares, weighted157m155m37m+318.6%
Shares outstanding at period end159m157m159m-0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Shareholders' equity890845-117n/a
Redeemable equity0.00.0n/an/a
Debt0.00.0n/an/a
Other liabilities93.570.3n/an/a
Total liabilities and equity983916n/an/a
Fixed assets35.121.8n/an/a
Investments761410n/an/a
Cash and equivalents12642137.7+234.3%
Receivables25.422.2n/an/a
Inventory24.428.6n/an/a
Other assets11.311.9n/an/a
Total assets983916n/an/a

Questions

What was Astera Labs' revenue in Q3 FY2024?

Astera Labs (ALAB) reported revenue of $113 million for Q3 FY2024, the quarter ended 30 September 2024, up 206.2% on the same quarter a year earlier.

How much did Astera Labs earn in Q3 FY2024?

Net loss for Q3 FY2024 was $8 million, and the diluted loss per share $0.05.

When did Astera Labs report Q3 FY2024 results?

Astera Labs filed its 10-Q for the quarter ended 30 September 2024 with the SEC on 5 November 2024.

Quarterly results, the last 14 quarters

Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024 †Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025 †Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue17.710.736.950.565.376.8113141159192231271308392
Cost of revenue13.42.28.811.514.717.025.236.640.046.454.866.173.2105
Gross profit4.38.428.139.050.559.987.9104119146176204235288
Gross margin24%79%76%77%77%78%78%74%75%76%76%76%76%73%
R&D15.317.920.619.753.640.150.756.564.666.778.993.8126136
Operating income-18.9-17.6-2.09.0-83.0-24.3-8.90.111.339.855.467.061.889.2
Operating margin-107%-165%-5%18%-127%-32%-8%0%7%21%24%25%20%23%
Pre-tax income-17.3-16.1-0.310.7-80.4-14.12.010.721.750.766.978.973.4103
Tax raten/an/an/a-34%n/an/a477%-131%-47%-1%-36%43%-9%-49%
Net income-17.5-20.0-3.114.3-93.0-7.5-7.624.731.851.291.145.080.3153
Net margin-99%-187%-8%28%-143%-10%-7%18%20%27%40%17%26%39%
Diluted EPS-$0.49-$0.55-$0.08n/a-$1.77-$0.05-$0.05$0.14$0.18$0.29$0.50$0.25$0.44$0.83
Operating cash flow-3.8-23.0-0.314.43.729.863.539.710.513578.295.374.687.7
Capital expenditure0.40.60.71.03.4n/a16.715.44.52.012.318.77.620.5
Free cash flow-4.3-23.5-1.113.40.2n/a46.824.36.013365.976.667.067.2
Shares outstanding156m157m159m42m155m157m159m162m165m166m169m170m171m173m
Filing10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A blank figure marked on a quarter is one the filings do not give on their own: the quarters as filed do not add to the year the company filed, or the year and its quarters stand on different share counts. Each quarter's page says which. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2024, filed 5 November 2024: the filing.